Article
Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia.
Nutrition, metabolism, and cardiovascular diseases : NMCD - 1 Oct 2012
Pisciotta L, Sallo R, Rabacchi C, Wunsch A, Calandra S, Bertolini S
Abstract excerpt
BACKGROUND AND AIMS: In the normal population, carriers of an additional leucine residue in a stretch of nine leucines in the signal peptide of PCSK9 (L10) have lower total (TC) and low-density lipoprotein cholesterol (LDL-C) than homozygotes for the wild-type allele (L9/L9). A similar effect was detected in familial hypercholesterolaemia (FH) patients with the p.C681X mutation of LDL-receptor (LDLR). We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
